Antepartum predictors of the development of type 2 diabetes in Latino women 11-26 months after pregnancies complicated by gestational diabetes

Diabetes

Volumn 48, Issue 12, 1999, Pages 2430-2436

  Buchanan, Thomas A ^a,c   Xiang, Anny H ^a   Kjos, Siri L ^a   Trigo, Enrique ^a   Lee, W Paul ^b   Peters, Ruth K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH AND CENTRAL AMERICA;

EID: 0033499585     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2430     Document Type: Article

References (48)

1. DeFronzo RA, Bonadonna RC, Ferrannini E: The pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
2. Beck-Neilsen H, Groop LC: Metabolic and genetic characterization of pre-diabetic states: sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest 94:1714-1721, 1994
3. Kruszynska YT, Olefsky JM: Cellular and molecular mechanisms of non-insulin-dependent diabetes mellitus. J Invest Med 44:413-428, 1996
4. Martin BC, Warram JH, Krolweski AS, Bergman RN, Soeldner JS, Kahn CR: Role of glucose and insulin resistance in the development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
5. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler W, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. N Engl J Med 329:1988-1992, 1992
6. Haffner SM, Miettinen H, Gaskill SP, Stern MP: Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican Americans. Diabetes 44:1386-1391, 1995
7. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in Pima Indians. N Engl J Med 319:1500-1505, 1988
8. Metzger BE, Cho NH, Roston SM, Rodvany R: Prepregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 16:1598-1605, 1993
9. Damm P, Kuhl C, Bertelsen A, Molsted-Pedersen L: Predictive factors for the development of diabetes in women with previous gestational diabetes mellitus. Am J Obstet Gynecol 167:607-616, 1992
10. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
11. Jeng CY, Sheu WH, Fuh MM, Chen YD, Reaven GM: Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 43:1440-1444, 1994
12. Beck-Neilsen H, Hother-Neilsen O, Vaag A, Alford F: Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycemia. Diabetologia 37:217-221, 1984
13. Gerich JE: Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 34:607-610, 1991
14. Fery F: Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting. J Clin Endocrinol Metab 78:536-542, 1994
15. O'Sullivan JB: Diabetes after GDM. Diabetes 40 (Suppl. 2):131-135, 1991
16. Henry OA, Bleischer NA: Long-term implications of gestational diabetes for the mother. Ballieres Clin Obstet Gynaecol 5:461-483, 1991
17. Persson B, Hanson U, Hartling SG, Binder C: Follow-up of women with previous GDM: insulin, C-peptide and proinsulin responses to oral glucose load. Diabetes 40 (Suppl. 2): 136-141, 1991
18. Mestman JH, Anderson GV, Guadalupe V: Follow-up studies of 360 subjects with abnormal carbohydrate metabolism during pregnancy. Obstet Gynecol 39:421-425, 1972
19. Kjos SL, Peters RK, Xiang A, Henry OA, Montoro MN, Buchanan TA: Predicting future diabetes in Latino women with gestational diabetes: utility of early postpartum glucose tolerance testing. Diabetes 44:586-591, 1995
20. Xiang AH, Peters RK, Trigo E, Kjos SL, Lee WP, Buchanan TA: Multiple metabolic defects during late pregnancy in women at high risk for type 2 diabetes mellitus. Diabetes 48:848-854, 1999
21. Buchanan TA, Xiang A, Kjos SL, Lee WP, Trigo Nader I, Bergner A, Palmer JL, Peters RK: Gestational diabetes mellitus: antepartum metabolic characteristics that predict postpartum glucose intolerance and type 2 diabetes. Diabetes 47:1308-1316, 1998
22. Buchanan TA: Measurement of insulin sensitivity in pregnancy with glucose clamps and the minimal model. In The Minimal Model Approach and Determinants of Glucose Tolerance. Bergman RN, Lovejoy JC, Eds. Baton Rouge, LA, Louisiana State University Press, 1997, p. 323-343
23. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabelled and labelled exogenous glucose infusates. Diabetes 36:914-924, 1987
24. American Diabetes Association Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
25. Szafranek J, Paffenberger CD, Horner EC: The mass spectra of some per-O-acetylaldononitriles. Carbohydrate Res 38:97-105, 1974
26. Catalano PM, Wong WW, Drago NM, Amini SB: Estimating body composition in late gestation: a new hydration constant for body density and total body water. Am J Physiol 268-E153-E158, 1995
27. Bergman RN, Phillips LS, Cobelli C: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467, 1981
28. Bergman RN: Toward a physiological understanding of glucose tolerance: minimal model approach. Diabetes 38:1512-1528, 1989
29. Buchanan TA: Carbohydrate metabolism in pregnancy: normal physiology and implications for diabetes mellitus. Isr J Med Sci 27:432-441, 1991
30. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and B-cell function in human subjects: evidence for a hyperbolic function. Diabetes 42:1663-1672, 1993
31. O'Sullivan JB, Mahan CM: Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278-285, 1964
32. Pettitt DJ, Knowler WC, Baird HR, Bennett PH: Gestational diabetes: infant and maternal complications of pregnancy in relation to third-trimester glucose tolerance in the Pima Indians. Diabetes Care 3:458-464, 1980
33. Cocilovo G, Tomasi F, Guerra S, Zampini A, Cocurullo A: Risk factors associated with persistence of glucose intolerance one year after gestational diabetes. Diabetes Metab 16:187-190, 1990
34. Catalano PM, Vargo KM, Bernstein IM, Amini SB: Incidence and risk factors associated with abnormal glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol 165:914-919, 1991
35. Coustan DR, Carpenter MW, O'Sullivan PS, Carr SR: Gestational diabetes: predictors of subsequent disordered glucose metabolism. Am J Obstet Gynecol 168:1139-1145, 1993
36. 13C NMR. Science 254:573-576, 1991
37. 13C nuclear magnetic resonance study. J Clin Invest 90:1323-1327, 1992
38. Gerich JE: Renal glucose production and utilization: new aspects in humans. Diabetologia 40:749-757, 1997
39. Metzger BE, Ravnikar V, Vileisis RA, Freinkel N: "Accelerated starvation" and the skipped breakfast in late normal pregnancy. Lancet i:588-592, 1982
40. Buchanan TA, Metzger BE, Freinkel N: Accelerated starvation in late pregnancy: a comparison between obese normal pregnant women and women with gestational diabetes mellitus. Am J Obstet Gynecol 162:1015-1020, 1990
41. Osei K: Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM. Diabetes 39:597-601, 1990
42. Mitrakou A, Kelley D, Mokan M, Veneman T, Pangburn T, Reilly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
43. Rebrin K, Steil GM, Mittelman SD, Bergman RN: Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749, 1996
44. Saloranta C, Fransilla-Kallunki A, Ekstrand A, Taskinen MR, Groop L: Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes. Diabetologia 34:409-415, 1991
45. Lewis GF, Vranic M, Harley P, Giaca A: Fatty acids mediate the acute extra-hepatic effects of insulin on hepatic glucose production in humans. Diabetes 46:1111-1119, 1997
46. Peters RK, Kjos SL, Xiang A, Buchanan TA: Long-term diabetogenic effect of a single pregnancy in women with prior gestational diabetes mellitus. Lancet 347:227-230, 1996
47. Pettitt DJ, Venkat Narayan KM, Hanson RL, Knowler WC: Incidence of diabetes mellitus in women following impaired glucose tolerance in pregnancy is lower than following impaired glucose tolerance in the non-pregnant state. Diabetologia 39:1334-1337, 1996
48. Cavaghan M, Ehrman DA, Byrne MM, Polonsky KS: Treatment with the oral antidiabetic agent troglitazone improves B-cell responses to glucose in subjects with impaired glucose tolerance. J Clin Invest 100:530-537, 1997